Search

Background: Sorafenib included in Chinese medical insurance is the earliest targeted drug for radioactive iodine refractory differentiated thyroid cancer (RR-DTC). This study is to further demonstrate the clinical efficacy and safety of sorafenib used in Zhujiang Hospital of Southern Medical University., Methods: RR-DTC patients treated at our Department of Nuclear Medicine in Zhujiang Hospital of Southern Medical University (October 2017-May 2020) were retrospectively analyzed. Treatment effects, progression-free survival (PFS), and adverse effects (AEs) during medication were evaluated., Results: Of the 31 patients included, 26 patients were evaluated for efficacy with a median follow-up time of 17.5 months (4.0-51.0 months). The disease control rate (DCR) was 57.7% ( n = 15) and the objective response rate (ORR) was 26.9% ( n  = 7). Most patients with disease control had thyroglobulin decreases of more than 60% ( p = 0.004), ORRs were favorable in patients with lung metastasis and lung-only metastasis ( p = 0.010 and 0.001, respectively). The PFS of the 26 patients analyzed was 16.5 months (95%CI: 14.41 -23.90 months). In the subgroup analysis, female, patients with lung-only metastasis, hand-foot skin syndrome (HFS), and thyroglobulin response ≥ 60% observed longer PFS ( p = 0.038, 0.045, 0.035, and 0.000, respectively), while patients with bone metastasis had lower PFS ( p = 0.035). The most common toxicity profile was HFS (93.5%), followed by diarrhea (83.9%), alopecia (74.2%). All the side effects were mainly grade 1-2. Grade 3-4 adverse reactions were more common in diarrhea and HFS., Conclusions: Sorafenib has promising efficacy in RR-DTC, especially in patients with lung metastasis and lung-only metastasis. The AEs of sorafenib were generally mild, and the main AE was HFS., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Ling, Xiong, Luo, Zou, Chen, Pan, Long, Feng and Ouyang.)

Many types of clay tend to absorb organics via electron transferring interactions between the clay and the organics. This may be utilized to design clay incorporated polymer composites with better interfacial properties. In the present paper, 2,5-bis(2-benzoxazolyl) thiophene (BBT), capable of donating electrons, is selected as the interfacial modifier for polypropylene (PP)/halloysite nanotube (HNTs) composites. The electron transfer between HNTs and BBT are confirmed. The mechanical properties and the unique morphology of the nanocomposites are examined. Formation of fibrils of BBT in the presence of HNTs is found in the nanocomposites. The chemical composition of the fibrils in the nanocomposites is found to be composed of largely BBT and a small amount of HNTs. The formation mechanism of BBT fibrils are elucidated to be the strong interactions between BBT and HNTs under melt shearing. The formation of the BBT fibrils leads to much higher crystallinity compared with previously reported PP nanocomposites. The nanocomposites with BBT show substantially increased tensile and flexural properties, which are attributed to the enhanced crystallinity of the nanocomposites.